AstraZeneca vaccine guards against severe COVID-19 illness

Dual treatments help PTSD and depression
4 February 2021
Austria sounds alarm over virus variant in Tyrol region
4 February 2021

AstraZeneca vaccine guards against severe COVID-19 illness

New data show that the vaccine developed by the University of Oxford and AstraZeneca not only protects people from serious illness and death, but also slows the transmission of the virus. The Oxford researchers say their findings offer the first evidence that any COVID-19 vaccine can reduce transmission of the virus, The New York Times reported.

Comments are closed.